TY  - GEN
AU  - Munyentwali,Helene
AU  - Bouachi,Khedidja
AU  - Audard,Vincent
AU  - Remy,Philippe
AU  - Lang,Philippe
AU  - Mojaat,Rachid
AU  - Deschênes,Georges
AU  - Ronco,Pierre M
AU  - Plaisier,Emmanuelle M
AU  - Dahan,Karine Y
TI  - Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease
SN  - 1523-1755
PY  - 2013///0820
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - adverse effects
KW  - Antigens, CD19
KW  - analysis
KW  - Antigens, CD20
KW  - immunology
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - therapeutic use
KW  - Male
KW  - Middle Aged
KW  - Nephrosis, Lipoid
KW  - drug therapy
KW  - Prednisone
KW  - Recurrence
KW  - Retrospective Studies
KW  - Rituximab
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/ki.2012.444
ER  -